Zobrazeno 1 - 10
of 2 622
pro vyhledávání: '"Ventricular tachyarrhythmias"'
Autor:
Hans Ebbinghaus, Laura Ueberham, Daniela Husser-Bollmann, Andreas Bollmann, Ingo Paetsch, Cosima Jahnke, Ulrich Laufs, Borislav Dinov
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/c2711d61e63746589095e2342d8f50b7
Autor:
Hans Ebbinghaus, Laura Ueberham, Daniela Husser-Bollmann, Andreas Bollmann, Ingo Paetsch, Cosima Jahnke, Ulrich Laufs, Borislav Dinov
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Cardiac sarcoidosis (CS), a rare condition characterized by non-caseating granulomas, can manifest with symptoms such as atrioventricular block and ventricular tachycardia (VT), as well as mimic inherited cardiomyopathies. A 48-year-old male presente
Externí odkaz:
https://doaj.org/article/a5a0d791a3614f7688f08c591a25dcec
Autor:
N. N. Ilov, O. V. Petrova, K. D. Tverdokhlebova, K.D. E. Yotio, A. A. Nechepurenko, S. A. Boytsov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 9 (2023)
Aim. To conduct a comparative analysis of blood biomarker concentrations, to study their prognostic role in the occurrence of sustained ventricular tachyarrhythmia (VT) or VT episodes requiring electrotherapy in patients with heart failure (HF) and l
Externí odkaz:
https://doaj.org/article/649358bab3414c60a26ba6cae1268b24
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/43224c1d9f43472da7c2728ec8ea8c90
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 5 (2023)
Aim. To evaluate the impact of cardiac resynchronization therapy (CRT) on the risk of sustained ventricular tachyarrhythmias (VT) in patients with heart failure (HF) with a implantable cardioverter-defibrillator (ICD) for the primary prevention of su
Externí odkaz:
https://doaj.org/article/311e96f6d4c34a5d8962e631c5b74538
Autor:
Víctor Marcos-Garcés, Nerea Perez, Jose Gavara, Maria P. Lopez-Lereu, Jose V. Monmeneu, Cesar Rios-Navarro, Elena de Dios, Hector Merenciano-González, Ana Gabaldon-Pérez, Ángel Ferrero-De-Loma-Osorio, Ángel Martínez-Brotons, Lourdes Bondanza, Juan Miguel Sánchez-Gómez, Cristina Albiach, Julio Nunez, Antoni Bayés-Genís, Francisco J. Chorro, Ricardo Ruiz-Granell, Vicente Bodi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundImplantable cardioverter defibrillators (ICD) are effective as a primary prevention measure of ventricular tachyarrhythmias in patients with ST-segment elevation myocardial infarction (STEMI) and depressed left ventricular ejection fraction
Externí odkaz:
https://doaj.org/article/652b31db0f1b4fdc85f66aebc76a4128
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valentina Kutyifa, MD, PhD, FHRS, Mary W. Brown, MS, RN, Christopher A. Beck, PhD, Scott McNitt, MS, Crystal Miller, MS, Karlene Cox, BS, Wojciech Zareba, MD, PhD, Spencer Z. Rosero, MD, Marye J. Gleva, MD, Jeanne E. Poole, MD
Publikováno v:
Heart Rhythm O2, Vol 1, Iss 5, Pp 376-384 (2020)
Background: Outcomes of patients with nonischemic cardiomyopathy and low ejection fraction implanted with an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D), especially in contemporary, r
Externí odkaz:
https://doaj.org/article/36de822912fb4ad1958b6987ad6602e2
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 12 (2022)
According to current clinical guidelines, the risk of life-threatening ventricular tachyarrhythmias (VTAs) in patients with heart failure (HF) is determined by left ventricular ejection fraction (LVEF). The available clinical and experimental data in
Externí odkaz:
https://doaj.org/article/c882b0eaa9b0498da75e6c018f9c7cd9